Silke Gastine

University College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Invasive fungal infections are a major cause of morbidity and mortality for immunocompromised patients. Posaconazole is approved for treatment and prophylaxis of invasive fungal infection in adult patients, with intravenous, oral suspension, and gastroresistant/delayed-released tablet formulations available.

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (5)

Simon Skene

Professor of Medical Statistics

University of Surrey

UNITED KINGDOM

View details

Yingfen Hsia

Lecturer in Pharmacy Practice

The Queen's University Belfast

UNITED KINGDOM

View details

Christina Liossi

University of Southampton

UNITED KINGDOM

View details

Michelle Clements

University College London

UNITED KINGDOM

View details

Richard Francis Howard

University College London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Silke Gastine

Research Interests

Explore related searches

Contact this professor

Articles (10)

Model Based Estimation of Posaconazole Tablet and Suspension Bioavailability in Hospitalized Children Using Real-World Therapeutic Drug Monitoring Data in Patients Receiving Intravenous and Oral Dosing

Oral morphine versus transmucosal diamorphine for breakthrough pain in children: methods and outcomes: UK (DIPPER study) consensus

Global antibiotic dosing strategies in hospitalised children: Characterising variation and implications for harmonisation of international guidelines

Clinical pharmacokinetics and dose recommendations for posaconazole gastroresistant tablets in children with cystic fibrosis.

LaTeX tutorial for the standardization and automation of population analysis reports.

Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance

IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis.

Population pharmacokinetics and probability of target attainment in patients with sepsis under renal replacement therapy receiving continuous infusion of meropenem: Sustained low-efficiency dialysis and continuous veno-venous haemodialysis.

Systematic Review and Patient-Level Meta-Analysis of SARS-CoV-2 Viral Dynamics to Model Response to Antiviral Therapies.

An automated approach to identify scientific publications reporting pharmacokinetic parameters.

Collaborators (5)

Simon Skene

Yingfen Hsia

Christina Liossi

Michelle Clements

Richard Francis Howard

Make your next move.